Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can cardiac magnetic resonance imaging reclassify uremic cardiomyopathy in patients with end-stage renal failure?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 22–23 (2007)Cite this article

This article has been updated

boxed-textMark PB et al. (2006) Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 69: 1839–1845

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 03 February 2010

    In the version of this article initially published online and printed the acknowledgements section was missing the following sentence. "S. G. Myerson acknowledges support from the Oxford NIHR Biomedical Research Centre programme." The error has now been corrected in the HTML version of the article.

References

  1. Amann K and Ritz E (1996) Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 5: 102–106

    Article  CAS  Google Scholar 

  2. Judd RM et al. (2005) Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging. Nat Clin Pract Cardiovasc Med 2: 150–158

    Article  Google Scholar 

  3. Mahrholdt H et al. (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26: 1461–1474

    Article  Google Scholar 

  4. Maceira AM et al. (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111: 186–193

    Article  Google Scholar 

  5. Diez J et al. (2001) Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 16: 328–335

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice. Dr. Myerson would like to acknowledge support from the Oxford NIHR Biomedical Research Centre programme.

Author information

Author notes

  1. Department of Cardiovascular Medicine, University of Oxford, Level 5, John Radcliffe Hospital, Oxford OX3 9DU, UK saul.myerson@cardiov.ox.ac.uk

Authors and Affiliations

  1. SG Myerson is a clinical lecturer in cardiovascular medicine and Director of the cardiology course at the University of Oxford, UK.,

    Saul G Myerson

Authors
  1. Saul G Myerson
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myerson, S. Can cardiac magnetic resonance imaging reclassify uremic cardiomyopathy in patients with end-stage renal failure?. Nat Rev Cardiol 4, 22–23 (2007). https://doi.org/10.1038/ncpcardio0717

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0717

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing